Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.39 |
| ▸ | CES1 | P23141 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PPARG | P37231 | 6/20 | 0.36 |
| ▸ | PPARD | Q03181 | 6/20 | 0.36 |
| ▸ | PPARA | Q07869 | 6/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.36 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | FABP4 | P15090 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17363603 | 1.00 | CES2 (0.39) | CES2CES1SMN1; SMN2AKR1B1TSHR | |
| SCHEMBL17363645 | 0.98 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363810 | 0.98 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363644 | 0.98 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363811 | 0.98 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363849 | 0.93 | CES1 (0.36) | CES2CES1SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL17363851 | 0.93 | CES1 (0.36) | CES2CES1SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL25220702 | 0.90 | CES2 (0.42) | CES2CES1SMN1; SMN2AKR1B1TSHR | |
| SCHEMBL22590076 | 0.88 | CES2 (0.44) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL16013176 | 0.88 | CES2 (0.44) | CES2CES1TSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2966054-B1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-01-02 | — | — | EP | disclosed |
| US-10029969-B2 | Method of producing optically-active aldehyde | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| EP-2966054-A1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | Takasago International Corporation (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-20150376102-A1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| EP-0105288-B1 | CARBACYCLINE, PREPARATION AND UTILIZATION THEREOF | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-12-11 | — | — | EP | disclosed |
| EP-0055208-B1 | CARBACYCLINS, PROCESS FOR THEIR PREPARATION AND THEIR UTILIZATION AS PHARMACEUTICAL PREPARATIONS | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029969-B2 | Method of producing optically-active aldehyde | ALDH3A1, ALDH1A2, ADH1A | CES2 296/4885CES1 574/4885SMN1; SMN2 3481/4885 |
| US-20150376102-A1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | ALDH3A1, ALDH1A2, ADH1A | CES2 296/4885CES1 574/4885SMN1; SMN2 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.